SCTX insider buying and SEC filings, explained
Scribe Therapeutics, Inc. · CIK 1853921
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$5.1M
Insiders who bought
3
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jul 27, 2026 | Purchase (code P) | Marc L Andreessen (10% owner) bought 333,333 shares indirectly (by entity) at $15.00 ($5.0M), reported as a purchase (code P). Holdings by entity up 16% to 2,385,075 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 5 other reporting owners. | SEC filing Filed Jul 29, 2026 |
| Jul 27, 2026 | Other purchase | Carl L. Gordon (Director) bought 1,000,000 Common Stock indirectly at $15.00 ($15.0M) in a public offering. Indirect holdings up 287% to 1,348,825 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 29, 2026 |
| Jul 27, 2026 | Other purchase | ORBIMED ADVISORS LLC (Director) bought 1,000,000 Common Stock indirectly at $15.00 ($15.0M) in a public offering. Indirect holdings up 287% to 1,348,825 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Jul 29, 2026 |
| Jul 24–28, 2026 | Other purchase | Behzad Aghazadeh (Director and Officer) bought 2,391,238 Common Stock, par value $0.0001 per share indirectly between Jul 24 and Jul 28 at about $15.16 ($36.3M) in a public offering. Indirect holdings up 343% to 3,088,888 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Jul 28, 2026 |
| Jul 23, 2026 | Purchase (code P) | David Parrot (CFO) bought 2,666 shares indirectly (by spouse) at $15.00 ($40K), reported as a purchase (code P). New position of 1,333 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 27, 2026 |
| Jul 23, 2026 | Purchase (code P) | Svetlana Lucas (Chief Business Officer) bought 3,000 shares indirectly (by spouse) at $15.00 ($45K), reported as a purchase (code P). New position of 3,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 27, 2026 |
12 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
3 insiders bought in 30 days
$5.1M in purchases since Jul 23, 2026 · Purchases traded Jul 23, 2026 to Jul 27, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Svetlana Lucas (Chief Business Officer) | $45K | Jul 23, 2026 | SEC filing |
| David Parrot (CFO) | $40K | Jul 23, 2026 | SEC filing |
| Marc L Andreessen (10% owner) | $5.0M | Jul 27, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow SCTX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.